(a), (b), (c), (d) and (f): Not applicable.

(e) On June 2, 2009, at the Annual Meeting of Stockholders (the "Annual Meeting") of Caliper Life Sciences, Inc. (the "Company"), the Company's stockholders approved the Caliper Life Sciences, Inc. 2009 Equity Incentive Plan (the "2009 Equity Plan"). A description of the material terms of the 2009 Equity Plan is set forth under the heading "Proposal 3 - Approval of the 2009 Equity Incentive Plan" in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 28, 2009 (the "Proxy Statement"), which description is incorporated by reference into this Item 5.02. The foregoing description of the 2009 Equity Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the 2009 Equity Plan, a copy of which is included as Appendix A to the Proxy Statement and is incorporated herein by reference.

The Company's stockholders also elected the following individuals at the Annual Meeting to serve as directors of the Company until the 2012 Annual Meeting of Stockholders and until their successors are duly elected and qualified:
Ms. Kathryn Tunstall, Mr. E. Kevin Hrusovsky and Mr. David W. Carter. The Company's stockholders also ratified the Audit Committee's selection of Ernst & Young LLP as auditors of the Company's financial statements for the fiscal year ending December 31, 2009.

(a), (b) and (c): Not applicable.

(d) Exhibits

Exhibit
Number                            Description of Document

10.1      2009 Equity Incentive Plan (incorporated by reference to Appendix A of
          the Company's Definitive Proxy Statement on Schedule 14A filed
          April 28, 2009).